Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis. [NA]

View source ↗

Summary

A clinical trial at Minia University is recruiting to compare Concerned Growth Factor and Miniral Trioide Aggregate for managing irreversible pulpitis in mature…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Concerned Growth Factor
  • Miniral Trioide Aggregate

Snippet

Sponsor: Minia University | Conditions: Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis | NA | Status: RECRUITING